See up to 3 months of QTTB. The 7-day demo opens the 1M and 3M ranges and puts QTTB on your watchlist.
Start 7-day demoLatest QTTB insider trades
About Q32 Bio Inc. (QTTB)
Q32 Bio Inc. is an SEC registrant, filing under CIK 0001661998, classified as pharmaceutical preparations. We track it alongside the rest of the Health Care sector.
QTTB Form 4 activity by transaction type, last 90 days
| Form 4 transaction type | Transactions | Shares | Total value |
|---|---|---|---|
| Open-market sale | 3 | 16,615 | $275K |
| Grant or award | 11 | 309,358 |
Dollar totals cover purchases and sales only (codes P and S). Grants, option exercises, gifts and tax withholding are counted in shares, because none of them is a trade at a market price.
QTTB insider transactions (Form 4)
3349 Form 4 filings on record, the earliest from Oct 10, 2024, newest first. Filing history page 1 of 2.
| Date | Insider | Transaction | Security | Shares | Price | Value |
|---|---|---|---|---|---|---|
| Jodie Pope Morrison - Officer | Open-market sale | Common Stock | 9,845 | $16.56 | $163K | |
| Lee Kalowski - Officer | Open-market sale | Common Stock | 3,972 | $16.56 | $66K | |
| Shelia M. Violette - Officer | Open-market sale | Common Stock | 2,798 | $16.56 | $46K | |
| Arthur Tzianabos | Grant or award | Stock Option (Right to Buy) | 10,826 | $0.00 | - | |
| Sven Ante Lundberg | Grant or award | Stock Option (Right to Buy) | 10,826 | $0.00 | - | |
| Kathleen Laporte | Grant or award | Stock Option (Right to Buy) | 10,826 | $0.00 | - | |
| Mark T. Iwicki | Grant or award | Stock Option (Right to Buy) | 10,826 | $0.00 | - | |
| Diyong Xu | Grant or award | Stock Option (Right to Buy) | 10,826 | $0.00 | - | |
 Isaac Manke | Grant or award | Stock Option (Right to Buy) | 10,826 | $0.00 | - | |
| David S. Grayzel | Grant or award | Stock Option (Right to Buy) | 10,826 | $0.00 | - | |
 Mary Thistle | Grant or award | Stock Option (Right to Buy) | 10,826 | $0.00 | - | |
| Shelia M. Violette - Officer | Grant or award | Common Stock | 37,500 | $0.00 | - | |
| Jodie Pope Morrison - Officer | Grant or award | Common Stock | 132,000 | $0.00 | - | |
| Lee Kalowski - Officer | Grant or award | Common Stock | 53,250 | $0.00 | - | |
| Isaac Manke | Option exercise | Common Stock | 53,521 | $2.80 | $150K | |
| Isaac Manke | Option exercise | Stock Option (Right to Buy) | 53,521 | $0.00 | - | |
| Kathleen Laporte | Grant or award | Stock Option (Right to Buy) | 9,810 | $0.00 | - | |
| Mark T. Iwicki | Grant or award | Stock Option (Right to Buy) | 9,810 | $0.00 | - | |
| Isaac Manke | Grant or award | Stock Option (Right to Buy) | 9,810 | $0.00 | - | |
| Arthur Tzianabos | Grant or award | Stock Option (Right to Buy) | 9,810 | $0.00 | - | |
| David S. Grayzel | Grant or award | Stock Option (Right to Buy) | 9,810 | $0.00 | - | |
| Mary Thistle | Grant or award | Stock Option (Right to Buy) | 9,810 | $0.00 | - | |
| Diyong Xu | Grant or award | Stock Option (Right to Buy) | 9,810 | $0.00 | - | |
| Sven Ante Lundberg | Grant or award | Stock Option (Right to Buy) | 9,810 | $0.00 | - | |
| Diyong Xu - Director | Open-market purchase | Common Stock | 1,250,000 footnote F1 | $8.00 | $10.00M | |
| Diyong Xu - Director | Open-market purchase | Common Stock | 625,000 footnote F1 | $8.00 | $5.00M | |
| ||||||
| ORBIMED ADVISORS LLC - Director | Open-market purchase | Common Stock | 1,250,000 footnote F1 | $8.00 | $10.00M | |
| ORBIMED ADVISORS LLC - Director | Open-market purchase | Common Stock | 625,000 footnote F1 | $8.00 | $5.00M | |
| ||||||
| Shelia M. Violette - Officer | Grant or award | Common Stock | 37,500 | $0.00 | - | |
| Lee Kalowski - Officer | Grant or award | Common Stock | 53,250 | $0.00 | - | |
| Jodie Pope Morrison - Officer | Grant or award | Common Stock | 132,000 | $0.00 | - | |
| Lee Kalowski - Officer | Open-market sale | Common Stock | 3,995 | $4.51 footnote F2 | $18K | |
| ||||||
| Jodie Pope Morrison - Officer | Open-market sale | Common Stock | 9,896 | $4.51 footnote F2 | $45K | |
| ||||||
QTTB insider trading FAQ
What is the latest insider trade for QTTB?
Q32 Bio Inc. (QTTB) had 14 insider filings in the last 90 days, with the most recent on 2026-08-27. The full record for QTTB runs to 49 Form 4 filings, the earliest from 2024-10-10. InsiderAlpha adds new Form 4, Form 144 and 8-K filings as they arrive from SEC EDGAR.
How many insiders are buying QTTB stock?
No insider purchases of QTTB were filed in the last 90 days. 4 purchases are on record for this company.
How many insiders are selling QTTB stock?
3 insider sales of QTTB were filed in the last 90 days, totaling $275K.
Where can I see QTTB SEC filings (Form 4, 10-K, 10-Q, 8-K)?
This page collects QTTB Form 4 insider transactions, Form 144 sale notices and 8-K filings in one place. Annual 10-K and quarterly 10-Q reports live on the company's SEC EDGAR page.
More Health Care companies with insider activity
Recent insider filings
10The EDGAR links open each original Form 4, so you can check any number on this page against the filing it came from.
- - Jodie Pope Morrison view on EDGAR
- - Lee Kalowski view on EDGAR
- - Shelia M. Violette view on EDGAR
- - Arthur Tzianabos view on EDGAR
- - Sven Ante Lundberg view on EDGAR
- - Kathleen Laporte view on EDGAR
- - Mark T. Iwicki view on EDGAR
- - Diyong Xu view on EDGAR
- - Isaac Manke view on EDGAR
Related companies with recent insider activity
Learn more
- Insider selling: signal or noise?
- Why most insider sales are routine, and the few patterns worth a second look.
- Insider activity in Health Care
- Where QTTB's peers are being bought and sold.
- Every recent Form 4
- The market-wide feed, updated as filings arrive from SEC EDGAR.
Follow QTTB with a 7-day demo
- QTTB on your watchlist
- Every QTTB Form 4 filing on record
- Up to 3 months of QTTB price history
- The daily trading plan of ranked insider buys, on a delay, with the plan archive
